Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
NCT06036004
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Central Diabetes Insipidus (cDI)
Interventions
DRUG:
Intranasal OXT
OTHER:
Placebo nasal spray
Sponsor
University Hospital, Basel, Switzerland